Halo Neuroscience Stock

Halo Neuroscience has developed a neurotech platform that unlocks human performance. Our first product, Halo Sport, is for elite athletes

Sign up today and learn more about Halo Neuroscience Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

Invest Now Sell Shares

Founded

2013

Notable Investors

Uncork Capital

Headquarters

San Francisco CA, US

Total Funding

$10.7M

About Halo Neuroscience Stock

Halo Neuroscience develops and markets neurotechnology systems to help individuals unlock their true potential. Their first product, Halo Sport, utilizes Neuropriming technology to accelerate skill and strength acquisition in elite athletes. The company was incorporated in 2013 and is based in San Francisco, CA.

Investors

Jazz Venture Partners

Pear Therapeutics, Akili Interactive Labs, Pymetrics, AllStripes, Halo Neuroscience

Uncork Capital

Human Interest, Shippo, Molekule, Front, Tempo Automation, Poshmark, Reputation.com, DroneDeploy, Niche.com, Halo Neuroscience

Funding History

July 2013	$150K
May 2014	$0
May 2014	$1.5M
February 2016	$9.0M

Management

Co-Founder & CEO

Daniel Chao

CMO

Mark Mastalir

Co-Founder

Amol Sarva

Co-Founder & Chief Technology Officer

Brett Wingeier

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Join Now

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2023 EquityZen Inc. All rights reserved.